• Ghana
  • Kenya
  • Nigeria
  • Tanzania
Where the impacts of the investment may be experienced.
Financial Institutions
  • Netherlands Development Finance Company (FMO)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Jul 15, 2020
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
The holder of the loan, grant, or other investment.
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 0.30 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Currency conversion note:
Bank reported EUR 0.26 MLN
Converted using 2020-07-15 exchange rate.
Primary Source

Original disclosure @ FMO website

Updated in EWS Nov 30, 2020

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description

PharmAccess is an international NGO headquartered in Amsterdam and offices in Sub-Sahara Africa (Kenya, Tanzania, Ghana and Nigeria) that aims at improving access to better quality care through loans for health SME's, quality standards and health insurance using mobile and digital technology.

The project aims to support healthcare providers, patients, and the local government in Ghana, with the current Covid-19 response and to ensure that the implemented processes and technologies stay in place post-Covid-19.

FMO- NLB's support will assist PhamAccess in implementing and rolling out the Covid-19 Monitor in Ghana, as the first African country to help reducing the spread of the virus and preparing the healthcare system and local authorities to better handle the COVID-19 response. The FMO development capital contribution of EUR 258,781 represents 50% of the investment required to introduce the COVID-19 Monitor as was developed by Luscii Healthtech B.V. and was in the Netherlands made available by OLVG, to Ghana where a remote care centre will be established and the solution will be made available for a USSD feature phone. After successful implementation in Ghana, it will also be made available to other countries such as Nigeria and Kenya.


Investment Description
  • Netherlands Development Finance Company (FMO)
Contact Information

Project contacts not available at the time of disclosure.



Communities who believe they will be negatively affected by a project funded by the Dutch Development Bank (FMO) may be able to file a complaint with the Independent Complaints Mechanism, which is the joint independent accountability mechanism of the Dutch Development Bank (FMO) and the German Investment Corporation (KfW) . A complaint can be filed in writing, by email, post, or online. The complaint can be filed in English or any other language of the complainant. The Independent Complaints Mechanism is comprised of a three-member Independent Expert Panel and it can provide either problem-solving, compliance review or both, in either order. Additional information about this accountability mechanism, including a guide and template for filing a complaint, can be found at: